期刊文献+
共找到28篇文章
< 1 2 >
每页显示 20 50 100
Case report of Graves' disease manifesting with odynophagia and heartburn 被引量:3
1
作者 Yulia Evsyutina Alexander Trukhmanov +2 位作者 Vladimir Ivashkin Olga Storonova Elina Godjello 《World Journal of Gastroenterology》 SCIE CAS 2015年第48期13582-13586,共5页
Graves' disease is an autoimmune disease, which can manifest with a variety of extrathyroidal clinical syndromes like ophthalmopathy, pretibial myxedema(dermopathy), acropathy, cardiomyopathy, and encephalopathy. ... Graves' disease is an autoimmune disease, which can manifest with a variety of extrathyroidal clinical syndromes like ophthalmopathy, pretibial myxedema(dermopathy), acropathy, cardiomyopathy, and encephalopathy. Though quite rare, this disease can also manifest with gastrointestinal symptoms such as dysphagia, heartburn, nausea, vomiting and diarrhea. We report a clinical case of Graves' disease manifesting with dysfunction of the esophagus and heartburn in a 61-year-old man. In the muscular layer of the esophagus we found dystrophic changes led to its atony, which was documented by endoscopy and high-resolution manometry. The pathology features of esophageal symptoms were: focal proliferation of the basal cells, vascular distension, and dystrophy of the epithelial cells. Antithyroid treatment led to decrease of all clinical symptoms after 5 d of Thiamazole administration. Complete restoration of peristalsis in the esophagus, according to manometry, was observed in 1 mo after initiation of treatment. 展开更多
关键词 graves' disease HEARTBURN ODYNOPHAGIA Esophagopathy DYSFUNCTION
下载PDF
Association between Free Triiodothyronine Levels and Peripheral Arterial Disease in Euthyroid Participants 被引量:5
2
作者 WANG Po DU Rui +8 位作者 LIN Lin DING Lin PENG Kui XU Yu XU Min BI Yu Fang WANG Wei Qing NING Guang LU Jie Li 《Biomedical and Environmental Sciences》 SCIE CAS CSCD 2017年第2期128-133,共6页
This current cross-sectional study investigates the relationship between thyroid hormones and peripheral artery disease (PAD) among euthyroid Chinese population aged 40 years and above. Serum free triiodothyronine ... This current cross-sectional study investigates the relationship between thyroid hormones and peripheral artery disease (PAD) among euthyroid Chinese population aged 40 years and above. Serum free triiodothyronine (FT3), free thyroxin (FT4), thyroid-stimulating hormone (TSH), and thyroid antibodies were measured. 展开更多
关键词 PAD Association between Free Triiodothyronine Levels and Peripheral Arterial disease in euthyroid Participants TPOAb HDL SBP LDL TSH FPG
下载PDF
Study on T lymphocyte subsets and NK cells in patients with Graves' disease combined with type 2 diabetes
3
作者 魏枫 杜婧 +3 位作者 苏秀兰 乌兰 王津京 霍晓静 《Journal of Pharmaceutical Analysis》 SCIE CAS 2008年第2期92-94,共3页
Objective To investigate changes in T lymphocyte subsets and NK cells in patients with simple Graves’ disease(GD)and Graves’ disease combined with type 2 diabetes mellitus(GD/T2DM).Methods Fifteen cases of GD/T2DM w... Objective To investigate changes in T lymphocyte subsets and NK cells in patients with simple Graves’ disease(GD)and Graves’ disease combined with type 2 diabetes mellitus(GD/T2DM).Methods Fifteen cases of GD/T2DM were selected from our hospital from November 2001 to November 2004.Before and after therapy thyroid function,thyroglobulin antibody(TGA),thyroid microsomal antibody(TMA)and blood glucose level were measured,and T lymphocyte subsets(CD3,CD4,CD8,CD4/CD8)and NK cells(CD56)were measured by immunofluorescence double labeling monoclonal antibody and flow cytometry,respectively.At the same time,comparison was made with simple GD(15 cases),T2DM(15 cases)and healthy control(20 cases).Results Before therapy,CD4/CD8,CD4 and NK cells in GD/T2DM were less than normal,and there was no significant difference in comparison with simple GD(P<0.05).In T2DM group,only CD4/CD8 and CD4 were less than those of healthy controls(P<0.05).When thyroid function recovered after 1 to 3 months of methimazole treatment in both GD/T2DM and simple GD groups,various indexes recovered,which were more obvious in simple GD.Conclusion Immune hypofunction of GD may be the key to the immune abnormality of GD/T2DM,which is more significant than that of simple GD or T2DM.The recovery of thyroid function and immune abnormality is not consistent,and the recovery of GD is more significant than that of GD/T2DM. 展开更多
关键词 graves' disease T lymphocyte subsets NK cells type 2 diabetes mellitus
下载PDF
THE CLINICAL SIGNIFICANCE OF TSAb IN GRAVES' DISEASE
4
作者 高慧 金世鑫 +3 位作者 宗建奇 李健 马秀萍 施秉银 《Journal of Pharmaceutical Analysis》 CAS 1994年第2期105-111,共7页
TSAb and TSBAb both were measured in i63 patients with Graves' disease(GD) and 31 Autoimmune Thyroiditis(AIT) individually and simultaneously. The TSAb activities and positive percentage in active and relapse GD ... TSAb and TSBAb both were measured in i63 patients with Graves' disease(GD) and 31 Autoimmune Thyroiditis(AIT) individually and simultaneously. The TSAb activities and positive percentage in active and relapse GD groups were higher than those in the normal control and euthyroidgroups; no significant difference was found between the active GD and relapse GD groups. TSAb were positive in one of 31 Patients with hypothyroidism due to AIT. TSBAb were positive in GD patients after treatment who became patients with hypothyroidism and patients with bypothyroidism dueto AIT, being 30. 0% and 35.5% respectively. TSAb and TSBAb were measured simultaneously in 35GD patients with different thyroid function status, and 4 PatientS with hypothyroidism due to AIT.We found that two patients with GD who were euthyroid during treatment with ATD and one patient with active GD had TSAb and TSBAb coexisting in circulation. we would postulate that perhaps only one kind of preponderant autoantibody activity could be detected and those nonpreponderant autoantibodies might be very difficultly found, when the patients were in a certain stable thyroid function saute. 展开更多
关键词 TSAb TSBAb graves' disease Autoimmune thyroiditis
下载PDF
THE EFFECT OF FCγ RECEPTOR ON THE PATHOGENESIS OF GRAVES' DISEASE
5
作者 蒲丹 郭辉 +2 位作者 雒文田 刘秋月 Aosai Fumie 《Journal of Pharmaceutical Analysis》 SCIE CAS 2004年第2期190-192,共3页
Objective To explore the roles of Fcγ recep tor in the pathogenesis of Graves' disease. Methods Fcγ receptor gene knockout mice(Fcγ R KO m ice) which were rooted in C57BL/6 mice and wild type C57BL/6 mice wer... Objective To explore the roles of Fcγ recep tor in the pathogenesis of Graves' disease. Methods Fcγ receptor gene knockout mice(Fcγ R KO m ice) which were rooted in C57BL/6 mice and wild type C57BL/6 mice were immunized by hTSH receptor expressing cells (DAP3.WT). 1-2×107 DAP3.WT cells were peri toneally injected into mice every two weeks for a total of six times. Two weeks after final immunization, mice were killed for measurement of total thyroxine, T RAb and pathological examination. Results The thyroxine level of the immunized Fcγ recept or gene knockout mice was significantly lower than that of the immunized wild ty pe control mice (2.2±0.31 vs. 3.32± 0.59 g·dL -1, P< 0.05 ),but there was no significant difference between immunized Fcγ R KO mic e and non-immunized wild type control group. The TRAb levels of the immunized F γ R KO mice significantly increased compared to those of the immunized wild type mice (21.75±8.21 vs. 14.11±6.21, P< 0.05). The lymphocyte cel ls infiltration and destruction of thyroid follicles were found in the thyroid gland of the immunized Fcγ R KO mice. Conclusion These results suggest that Fcγ receptor may be involved in the pathogenesis of Graves' disease. 展开更多
关键词 graves' disease Fcγ receptor gene knockou t thyroid gland
下载PDF
Induction of animal model of Graves' disease in BALB/c mice
6
作者 Zhu-fang Tian1,2,Bing-yin Shi1,Xiao-yan Wu1,Li Xu1 1.Department of Endocrinology,the First Affiliated Hospital,Medical School of Xi’an Jiaotong University,Xi’an 710061 2.Department of Endocrinology,Xi’an Central Hospital,Xi’an 710003,China 《Journal of Pharmaceutical Analysis》 SCIE CAS 2009年第4期211-214,221,共5页
Objective To construct an animal model of Graves’ disease(GD)by immunizing BALB/c mice with hM12 cells co-expressing major histocompatibility complex(MHC)class II molecules and human thyrotropin receptor(TSHR)molecul... Objective To construct an animal model of Graves’ disease(GD)by immunizing BALB/c mice with hM12 cells co-expressing major histocompatibility complex(MHC)class II molecules and human thyrotropin receptor(TSHR)molecules.Methods BALB/c mice in experimental group(H-2d)were immunized with hM12 cells intraperitoneally every 2 weeks for six times,while mice in control group were immunized with M12 cells.Five weeks later,the thyroids were histologically examined,and serum samples were tested for thyroid-stimulating antibodies(TSAb)and thyroid hormone levels.Results One BALB/c mouse in experimental group developed Graves’-like disease.Total T4 and T3 levels in this mouse were above the upper limit of normal,TSAb activity was displayed in its serum.The thyroid histologically showed the features of thyroid hyperactivity including thyrocyte hypercellularity and colloid ABSorption.None of control mice developed Graves’-like disease.Conclusion An animal model with some characteristics of human Graves’ disease was successfully induced and the model will facilitate studies aimed directly at understanding the pathogenesis of autoimmunity in Graves’ disease. 展开更多
关键词 major histocompatibility complex thyrotropin receptor M12 cell graves' disease
下载PDF
Free triiodothyronine in relation to coronary severity at different ages: Gensini score assessment in 4206 euthyroid patients 被引量:1
7
作者 Bing-Yang ZHOU Yuan-Lin GUO +8 位作者 Na-Qiong WU Cheng-Gang ZHU Ying GAO Ping QING Xiao-Lin LI Yao WANG Geng LIU Qian DONG Jian-Jun LI 《Journal of Geriatric Cardiology》 SCIE CAS CSCD 2016年第12期978-983,共6页
Objective To study whether free triiodothyronine (FT3) within normal range has effects on the presence and severity of coronary ar- tery disease (CAD) in different gender and age groups. Methods A total of 4206 eu... Objective To study whether free triiodothyronine (FT3) within normal range has effects on the presence and severity of coronary ar- tery disease (CAD) in different gender and age groups. Methods A total of 4206 euthyroid patients were consecutively enrolled and di- vided into CAD group (n = 3306) and non-CAD group (n = 900). All patients underwent coronary angiography (CAG). Gensini score (GS) was used to determine the severity of coronary artery stenosis. Severe CAD was defined as GS 〉 32 and mild CAD was defined as GS 〈 32. Logistic regression analysis and linear regression analysis were conducted to determine the association of FT3 with CAD in patients with different gender and ages. Results Concentration of FT3 was lower in patients with CAD than that in angiography-normal control group (P 〈 0.05). In addition, concentration of FT3 was lower in severe CAD than that in mild CAD. After adjusting for traditional cardiovascular risk factors and potential confounders, FT3 was negatively correlated with the presence of CAD, but not in the old patients (〉 65 years old). Mul- tivariable linear regression analysis showed that FT3 was negatively associated with GS in male and young patients with stable CAD, but not in the old patients. Conclusions Low FT3 within normal range was negatively associated with the presence and severity of CAD in young patients, but not in the old ones. Further studies are needed to confirm our findings. 展开更多
关键词 Coronary angiography Coronary artery disease euthyroidISM Free triiodothyronine Gensini score
下载PDF
甲状腺功能正常和甲状腺功能减退患者游离三碘甲状腺原氨酸与游离甲状腺素比值与非酒精性脂肪性肝病的相关性研究 被引量:10
8
作者 范尧夫 曹雯 +4 位作者 狄红杰 张会峰 孙洪平 曹琳 褚晓秋 《中国全科医学》 CAS 北大核心 2019年第32期3915-3920,共6页
背景甲状腺激素参与机体的能量平衡、脂质代谢,被认为可能是导致非酒精性脂肪性肝病(NAFLD发生的潜在机制之一。近些年,甲状腺激素与NAFLD之间的关系已成为临床研究热点,但相关研究结论仍有很大的争议。目的探讨甲状腺功能正常(ET)和甲... 背景甲状腺激素参与机体的能量平衡、脂质代谢,被认为可能是导致非酒精性脂肪性肝病(NAFLD发生的潜在机制之一。近些年,甲状腺激素与NAFLD之间的关系已成为临床研究热点,但相关研究结论仍有很大的争议。目的探讨甲状腺功能正常(ET)和甲状腺功能减退(甲减)患者的甲状腺激素水平与NAFLD患病风险的相关性。方法选取2015年3月-2018年3月在南京中医药大学附属中西医结合医院内分泌代谢院区住院的患者382例。按照甲状腺功能水平分为:ET组268例,甲减组114例。按照有无NAFLD分为:NAFLD组166例,非NAFLD组216例。采集患者甲状腺激素指标,分析其与NAFLD的相关性,并绘制受试者工作特征(ROC)曲线。结果 268例ET患者中,合并NAFLD 113例,非NAFLD 155例。ET合并NAFLD者腰围(WC)、游离三碘甲状腺原氨酸(FT3)/游离甲状腺素(FT4)比值、三酰甘油(TC)、低密度脂蛋白胆固醇(LDL-C)、空腹胰岛素(FINS)、胰岛素抵抗指数(HOMA-IR)均高于ET非NAFLD者(P<0.05)。114例甲减患者中,合并NAFLD 53例,非NAFLD 61例。甲减合并NAFLD者WC、促甲状腺激素(TSH)、FT3/FT4比值、TC、LDL-C、FINS、HOMA-IR均高于甲减非NAFLD者(P<0.05)。多因素Logistic回归分析结果显示,WC〔OR=1.564,95%CI(1.125,2.174)〕、FT3/FT4比值〔OR=1.255,95%CI(1.067,1.477)〕、HOMA-IR〔OR=1.922,95%CI(1.194,3.095)〕是NAFLD发生的影响因素(P<0.05);WC〔OR=1.233,95%CI(1.056,1.439)〕、FT3/FT4比值〔OR=1.628,95%CI(1.381,1.919)〕、TC〔OR=1.168,95%CI(1.014,1.345)〕、HOMA-IR〔OR=1.502,95%CI(1.053,2.142)〕是甲减患者发生NAFLD的影响因素(P<0.05)。ROC曲线结果显示,在纳入所有患者中FT3/FT4比值预测NAFLD患病风险的ROC曲线下面积(AUC)为0.707〔95%CI(0.611,0.809)〕,最佳切点值为0.37,灵敏度为78.2%,特异度为58.5%。在甲减患者中FT3/FT4比值预测NAFLD患病风险的AUC=0.746〔95%CI(0.570,0.865)〕,最佳切点值为0.47,灵敏度为82.4%,特异度为61.2%。结论 WC、FT3/FT4比值、HOMA-IR是NAFLD患病的危险因素。在甲减合并NAFLD患者中,TC也是患病危险因素。 展开更多
关键词 非酒精性脂肪性肝病 甲状腺功能正常 甲状腺功能减退症 甲状腺激素类 影响因素分析
下载PDF
慢性肾脏病患儿血清甲状腺素水平变化的意义 被引量:5
9
作者 李琪 肖群文 +2 位作者 贺湘英 徐静 赵亚玲 《实用儿科临床杂志》 CAS CSCD 北大核心 2008年第17期1349-1350,共2页
目的观察慢性肾脏病(CKD)患儿血清甲状腺激素水平变化及其临床意义。方法对78例CKD患儿进行分期(入院治疗前,患儿达到完全缓解后,住院治疗8周确定患儿未缓解时口服小剂量L-甲状腺素片4~6周),于清晨采取其空腹静脉血2~3mL,血标本均采... 目的观察慢性肾脏病(CKD)患儿血清甲状腺激素水平变化及其临床意义。方法对78例CKD患儿进行分期(入院治疗前,患儿达到完全缓解后,住院治疗8周确定患儿未缓解时口服小剂量L-甲状腺素片4~6周),于清晨采取其空腹静脉血2~3mL,血标本均采用放射免疫分析法检测其总甲状腺素(T4)、三碘甲状腺原氨酸(T3)、促甲状腺激素(TSH)等指标,观察其变化。采用SPSS11.0软件进行统计学分析。结果CKD患儿治疗前T3明显低于健康对照组(P<0.01),经治疗达到完全缓解时,其T3水平与治疗前及未缓解前比较,均明显升高(Pa<0.01);病情未缓解组T3明显低于健康对照组及缓解组(Pa<0.01),且出现T4下降,明显低于健康对照组及缓解组(Pa<0.01);各组TSH无明显改变(Pa>0.05);治疗无缓解患儿加用小剂量L-甲状腺素片后,T3、T4逐渐升高,与治疗前比较有显著性差异(Pa<0.05),并有部分患儿病情缓解。结论动态检测甲状腺激素水平可作为观察CKD患儿病情、判断疗效及评估预后的有效指标之一。 展开更多
关键词 慢性肾脏病 甲状腺激素 正常甲状腺功能病态综合征 儿童
下载PDF
冠心病患者甲状腺功能及FT3与冠状动脉病变关系的研究 被引量:8
10
作者 薛超 卞玲 +4 位作者 王长谦 解玉水 许左隽 陈启稚 殷兆芳 《心血管康复医学杂志》 CAS 2014年第5期506-509,共4页
目的:探讨冠心病患者甲状腺功能情况及游离甲状腺素(FT3)水平与冠脉病变的关系。方法:选择2012年至2014年期间入住我院,经冠脉造影证实的238名冠心病患者,分析其甲状腺功能情况;在排除甲亢、亚临床甲亢,甲状腺功能(甲减)、亚... 目的:探讨冠心病患者甲状腺功能情况及游离甲状腺素(FT3)水平与冠脉病变的关系。方法:选择2012年至2014年期间入住我院,经冠脉造影证实的238名冠心病患者,分析其甲状腺功能情况;在排除甲亢、亚临床甲亢,甲状腺功能(甲减)、亚临床甲减后,其余217例患者根据FT3水平被分为正常FT3组(192例)和低FT3组(25例),比较两组患者一般临床情况和冠脉造影结果。结果:(1)238名患者中甲亢2例(0.84%),甲减11例(4.62%),亚临床甲亢3例(1.26%),亚临床甲减5例(2.10%),低T3综合征25例(10.50%);(2)与正常FT3组比较,低FT3组患者总胆固醇[TC ,(4.14±1.59) mmol/L比(7.33±1.72) mmol/L]、载脂蛋白 E [ApoE ,(3.91±0.98) mmol/L比(4.55±1.52) mmol/L]、肌酐[Cr ,(97.99±30.85)μmol/L比(116.64±43.20)μmol/L]、N末端B型利钠肽原[NT-proBNP ,140(62-462) pg/ml比739(304-4922) pg/ml]水平显著升高(P均<0.01);(3)冠心病患者中FT3降低的患者合并三支病变的比例显著高于正常 FT3组(76.0%比40.1%, P<0.01)。结论:低游离甲状腺素综合征是冠心病患者最常见的甲状腺功能异常,游离甲状腺素水平降低的患者更容易多支血管受累。 展开更多
关键词 冠状动脉疾病 三碘甲状腺原氨酸 功能正常甲状腺病综合征
下载PDF
老年心血管疾病住院患者低T3综合征临床研究 被引量:3
11
作者 刘玥 龚玮琦 +2 位作者 邵莉 李明珠 江华 《医学临床研究》 CAS 2015年第4期765-766,770,共3页
【目的】探讨低T 3综合征在老年心血管疾病患者中的发生率及其临床意义。【方法】选择本院2009至2012年收治的390例老年心血管病患者,年龄60~75岁,其中急性心肌梗死106例,稳定性心绞痛86例,高血压患者120例,扩张性心肌病30例,慢... 【目的】探讨低T 3综合征在老年心血管疾病患者中的发生率及其临床意义。【方法】选择本院2009至2012年收治的390例老年心血管病患者,年龄60~75岁,其中急性心肌梗死106例,稳定性心绞痛86例,高血压患者120例,扩张性心肌病30例,慢性心力衰竭48例。采用化学发光免疫分析法测定上述各种病人的甲状腺激素水平。【结果】研究对象低T 3综合征发生率分别为:急性心肌梗死23.6%(25/106),稳定性心绞痛4.7%(4/86),高血压12.5%(15/120),扩张性心肌病23.3%(7/30),慢性心力衰竭22.9%(11/48)。在老年心血管疾病患者中,心功能越差的患者T3、游离三碘甲状腺原氨酸(FT3)水平越低。【结论】低 T3综合征在老年急危重症心血管疾病中发生率相对较高。T3、FT3水平与患者疾病的严重程度相关,可作为判断疾病预后的客观指标之一。 展开更多
关键词 心血管疾病/并发症 住院病人 功能正常甲状腺病综合征/并发症 老年人
原文传递
老年患者甲状腺激素水平与冠状动脉病变严重程度的临床研究 被引量:5
12
作者 汪蕾 蔡濛 张萍 《心肺血管病杂志》 2016年第7期520-523,共4页
目的:探讨甲状腺功能正常的老年患者甲状腺激素水平与冠状动脉病变及其严重程度的关系。方法:回顾143例因胸痛于我院行冠状动脉造影检查的甲状腺功能正常老年患者,根据冠状动脉造影结果分为冠心病组和无冠心病组,再计算所有患者冠状... 目的:探讨甲状腺功能正常的老年患者甲状腺激素水平与冠状动脉病变及其严重程度的关系。方法:回顾143例因胸痛于我院行冠状动脉造影检查的甲状腺功能正常老年患者,根据冠状动脉造影结果分为冠心病组和无冠心病组,再计算所有患者冠状动脉的Gensini积分,比较患者甲状腺激素水平与Gensini积分之间的关系。结果:(1)与非冠心病组相比较,冠心病组游离三碘甲状原氨酸(FT3)明显减低,差异有统计学意义(P=0.001);(2)血浆FT3水平与Gensini积分呈反比关系(r=-0.479,P〈0.001);(3)血浆FT3水平是冠状动脉严重病变的保护性因素(OR=0.055,95%CI:0.011-0.273,P〈0.001)。结论:在甲状腺功能正常的老年患者中,血浆FT3水平的降低与冠心病的发生相关,血浆FT3水平的降低预示着冠状动脉病变较严重,血浆FT3是冠状动脉病变的保护性因素,其水平的降低是冠状动脉病变严重程度的独立预测因子。 展开更多
关键词 甲状腺功能正常 冠心病 严重冠状动脉病变 老年人
下载PDF
甲状腺功能正常甲亢患者TSAb测定的临床意义
13
作者 郭长江 欧阳安 +1 位作者 苏天水 闫秀兰 《中国现代医学杂志》 CAS CSCD 1997年第4期6-6,19,共2页
应用克隆化鼠甲状腺细胞株(FRTL-5)的cAMP反应检测了17例正常人、18例甲状腺功能正常甲亢(EG)、29例未治甲亢(HG)的血清TSAb水平。正常组为(94.5±441)%(n=17,x±s),全部TSAb阴性;EG组为(465±486.7)%... 应用克隆化鼠甲状腺细胞株(FRTL-5)的cAMP反应检测了17例正常人、18例甲状腺功能正常甲亢(EG)、29例未治甲亢(HG)的血清TSAb水平。正常组为(94.5±441)%(n=17,x±s),全部TSAb阴性;EG组为(465±486.7)%(n=18),其中14例(77.8%)为阳性;HG组为(2205.1±3053)%(n=29),其中27例(93.1%)为阳性。EG组同HG组比较,阳性率无差异。但TSAb活性较HG级低(P<0.005)。结果表明,EG组患者存在自身免疫异常。因此TSAb的测定对EG的诊断具有重要意义。 展开更多
关键词 TSAb 甲状腺功能正常 甲状腺机能亢进 沉淀
下载PDF
血清三碘甲腺原氨酸水平与急性冠状动脉综合征病变特点及心功能变化的临床研究 被引量:2
14
作者 张丽晖 代文娟 +3 位作者 逯林欣 薛雪花 李蕊 李学文 《中国药物与临床》 CAS 2015年第11期1543-1546,共4页
目的探讨低三碘甲腺原氨酸(T3)综合征(ESS)T3水平与急性冠状动脉综合征(ACS)病变特点以及心功能指标的关系。方法采用回顾性病例分析,对217例ACS并ESS及非ESS患者的T3水平以及心功能指标进行分析,明确T3水平与ACS病变特点以及与心功能... 目的探讨低三碘甲腺原氨酸(T3)综合征(ESS)T3水平与急性冠状动脉综合征(ACS)病变特点以及心功能指标的关系。方法采用回顾性病例分析,对217例ACS并ESS及非ESS患者的T3水平以及心功能指标进行分析,明确T3水平与ACS病变特点以及与心功能指标的关系。结果 ACS合并ESS患者STEMI组总三碘甲腺原氨酸(TT3)、游离三碘甲腺原氨酸(FT3)值明显低于未合并组(P<0.05),NSTEMI以及不稳定型心绞痛(UA)患者合并ESS组TT3、FT3值低于未合并组,但差异无统计学意义(P>0.05);ACS合并ESS患者STEMI组FT3与TT3值与NSTEMI和UA组相比明显低下(P<0.05);STEMI广泛前壁或≥2部位梗死组TT3、FT3值低于单一部位梗死组(P<0.05);ACS合并ESS患者TIMI高危组FT3与TT3值与TIMI中危、低危组相比明显低下(P<0.05),且仅TIMI高危组与未合并组相比有统计学意义的降低(P<0.05);ACS患者合并ESS组NT-pro BNP高于未合并组(P<0.05),左心室射血分数(EF)值明显低于未合并组(P<0.05);c Tn I在合并ESS组以及未合并ESS组间差异无统计学意义。结论 ACS不同临床分型、不同TIMI危险等级、STEMI不同梗死部位TT3和FT3水平不同;ACS并ESS者心功能指标低下。T3水平的测定可能对ACS的诊断、病情判定、预后有一定的参考价值。 展开更多
关键词 冠状动脉疾病 功能正常甲状腺病综合征 TIMI危险评分 肌钙蛋白I 氨基末端脑钠肽前体
下载PDF
正常甲状腺病态综合征研究进展 被引量:9
15
作者 王凤 严宗逊 《中国医药导刊》 2020年第8期544-548,共5页
正常甲状腺病态综合征(euthyroid sick syndrome,ESS)又称为低T3综合征(low T3 syndrome,LT3S),或非甲状腺疾病综合征(nonthyroidal illness syndrome,NITs),是指急性或慢性全身性严重疾病导致机体甲状腺激素紊乱的非甲状腺性的疾病,临... 正常甲状腺病态综合征(euthyroid sick syndrome,ESS)又称为低T3综合征(low T3 syndrome,LT3S),或非甲状腺疾病综合征(nonthyroidal illness syndrome,NITs),是指急性或慢性全身性严重疾病导致机体甲状腺激素紊乱的非甲状腺性的疾病,临床主要体现在血清学检测异常:总三碘甲状腺原氨酸(TT3)、游离三碘甲状腺原氨酸(FT3)水平降低,反T3(rT3)水平升高,而促甲状腺素(TSH)水平正常。近年来许多研究显示,ESS与危重疾病的进展和不良预后密切相关,需引起临床工作者重视,且甲状腺激素替代治疗ESS是备受争议的话题,本文拟对ESS发病机制、与其他疾病的关联及预后、治疗等方面的研究进展进行综述,以期为临床治疗ESS提供参考。 展开更多
关键词 正常甲状腺病态综合征 发病机制 危重疾病 综述
下载PDF
低T_3综合征对左心疾病相关肺动脉高压患者再住院及死亡的影响研究 被引量:6
16
作者 聂美玲 刘乐 马涵英 《中国全科医学》 CAS 北大核心 2018年第14期1666-1671,共6页
目的分析低T_3综合征与左心疾病相关肺动脉高压(PH-LHD)患者再住院及死亡事件之间的关系,探讨低T_3综合征对PH-LHD患者病情评估及预后判断的价值。方法选取2015年首都医科大学附属北京安贞医院收治的154例PH-LHD患者,根据其入院后首次... 目的分析低T_3综合征与左心疾病相关肺动脉高压(PH-LHD)患者再住院及死亡事件之间的关系,探讨低T_3综合征对PH-LHD患者病情评估及预后判断的价值。方法选取2015年首都医科大学附属北京安贞医院收治的154例PH-LHD患者,根据其入院后首次测得游离三碘甲状腺原氨酸(FT_3)水平分为低T_3综合征组(n=41)及甲状腺功能正常组(n=113)。记录患者基本信息及实验室检查资料,并于2017年1月对患者进行电话随访,记录患者出院后到随访日期的再住院及死亡情况。结果低T_3综合征组失访2例,甲状腺功能正常组失访6例。低T_3综合征组再住院24例(61.5%),死亡18例(46.2%);甲状腺功能正常组再住院44例(41.1%),死亡17例(15.9%),低T_3综合征组再住院率及死亡率均高于甲状腺功能正常组(χ~2=7.283,P=0.01;χ~2=15.288,P<0.01)。多因素Cox比例风险回归模型分析结果显示,低T_3综合征与PH-LHD患者出院后再住院无明显相关性[HR=0.849,95%CI(0.441,1.637),P=0.625];脑钠钛(BNP)>400 ng/L[HR=2.496,95%CI(1.014,6.146),P=0.047]和低T_3综合征[HR=2.353,95%CI(1.092,5.066),P=0.029]是PH-LHD患者死亡的独立危险因素。血清FT_3预测LH-PHD患者死亡的受试者工作特征(ROC)曲线下面积为0.759[95%CI(0.664,0.854)],最佳临界值为FT_3<4.195 pmol/L;BNP预测患者死亡的ROC曲线下面积为0.800[95%CI(0.710,0.891)],最佳临界值为BNP>600 ng/L。De Long检验结果显示,两者ROC曲线下面积比较,差异无统计学意义(Z=0.693,P=0.488)。结论低T_3综合征是PH-LHD患者出院后死亡的独立危险因素,常规检测FT_3水平对PH-LHD患者进行危险分层及预后判断具有重要意义。 展开更多
关键词 左心疾病相关肺动脉高压 功能正常甲状腺病综合征 死亡
下载PDF
老年卧床感染患者的正常甲状腺功能病态综合征 被引量:4
17
作者 杨月花 刘全中 《中国实用医药》 2014年第34期18-20,共3页
目的探讨老年卧床感染患者甲状腺激素水平与病情严重程度及预后的关系。方法用放射免疫法测定48例老年卧床感染患者(卧床组)血浆三碘甲状腺原氨酸(T3)、甲状腺素(T4)及促甲状腺素(TSH)水平,并与45例非卧床老年感染患者(对照组)作比较,... 目的探讨老年卧床感染患者甲状腺激素水平与病情严重程度及预后的关系。方法用放射免疫法测定48例老年卧床感染患者(卧床组)血浆三碘甲状腺原氨酸(T3)、甲状腺素(T4)及促甲状腺素(TSH)水平,并与45例非卧床老年感染患者(对照组)作比较,观察两组的差异性。结果与对照组比较,卧床患者T3、T4均明显降低,差异有统计学意义(P<0.01),TSH两组比较,差异无统计学意义(P>0.05)。卧床组中死亡12例,其T3、T4水平均明显低于该组中成活者,差异有统计学意义(P<0.01)。结论老年卧床患者中存在正常甲状腺功能病态综合征,并可作为预后不良的指标。 展开更多
关键词 老年病 卧床患者 感染 正常甲状腺病态综合征
下载PDF
Identification of a combination of SNPs associated with Graves' disease using swarm intelligence 被引量:6
18
作者 WEI Bin PENG QinKe +1 位作者 ZHANG QuanWei LI ChenYao 《Science China(Life Sciences)》 SCIE CAS 2011年第2期139-145,共7页
Graves' disease,the production of thyroid-stimulating hormone receptor-stimulating antibodies leading to hyperthyroidism,is one of the most common forms of human autoimmune disease.It is widely agreed that complex... Graves' disease,the production of thyroid-stimulating hormone receptor-stimulating antibodies leading to hyperthyroidism,is one of the most common forms of human autoimmune disease.It is widely agreed that complex diseases are not controlled simply by an individual gene or DNA variation but by their combination.Single nucleotide polymorphisms(SNPs),which are the most common form of DNA variation,have great potential as a medical diagnostic tool.In this paper,the P-value is used as a SNP pre-selection criterion,and a wrapper algorithm with binary particle swarm optimization is used to find the rule for discriminating between affected and control subjects.We analyzed the association between combinations of SNPs and Graves' disease by investigating 108 SNPs in 384 cases and 652 controls.We evaluated our method by differentiating between cases and controls in a five-fold cross validation test,and it achieved a 72.9% prediction accuracy with a combination of 17 SNPs.The experimental results showed that SNPs,even those with a high P-value,have a greater effect on Graves' disease when acting in a combination. 展开更多
关键词 graves' disease single nucleotide polymorphism case-control study swarm intelligence
原文传递
A Study on Neonatal Tolerance Against Graves' Disease in BALB/c Mice 被引量:2
19
作者 Li-PingWu Li-Ru Xun +2 位作者 Li Xu Amir Hussain Bing-Yin Shi 《Chinese Medical Journal》 SCIE CAS CSCD 2015年第23期3243-3246,共4页
INTRODUCTION Autoimmunity is defined as, a condition characterized by a specific humoral or cell-mediated immune response against the constituents of the body's own tissues (autoantigens). In numerous autoimmune di... INTRODUCTION Autoimmunity is defined as, a condition characterized by a specific humoral or cell-mediated immune response against the constituents of the body's own tissues (autoantigens). In numerous autoimmune diseases, such an immune response is well recognized that causes damage to the self-constituents of body tissues by the products of the immune system. Graves' hyperthyroidism occurs after the loss of tolerance to the thyroid stimulating hormone receptor (TSHR) and the generation of thyroid stimulatory antibodies that mimic the action of thyroid-stimulating hormone (TSH). 展开更多
关键词 Animal Model graves' disease Immune Tolerance Thyroid Stimulating Hormone Receptor
原文传递
Preliminary Study on Chinese Drug-Induced Apoptosis of Thyrocytes in Graves' Disease 被引量:1
20
作者 赵家军 高 聆 +1 位作者 柳欣琦 刘雪萍 《Chinese Journal of Integrative Medicine》 SCIE CAS 2000年第3期196-199,共4页
Objective: To investigate the cellular and molecular mechanisms of some Chinese drugs on apoptosis of thyrocytes in Graves' disease. Methods: Two to ten weeks before and after using Chinese drugs on 13 Graves'... Objective: To investigate the cellular and molecular mechanisms of some Chinese drugs on apoptosis of thyrocytes in Graves' disease. Methods: Two to ten weeks before and after using Chinese drugs on 13 Graves' disease patients with anti-thyroid drugs, patients' thyroid tissue was aspired with percutaneous puncturing needle. The effects of some Chinese drugs on thyrocytes was studied by applying cell morphology (stained with nuclear fast red, NFR), flow cytometry (stained with propidium iodide, PI), and terminal uridine deoxynucleotidyl end-labelling (TUNEL) technique (alkaline phosphatase and CBIP/NBT, NFR). The size of thyroid gland was measured by color Doppler ultrasonography. Results: After Chinese drug treatment, compared with single anti-thyroid drug group, the size of thyroid was significantly reduced (P<0.01). The apoptosis of thyrocytes can be observed by cell morphology such as chromatin condensation and nuclear fragmentation. The apoptosis rate is 18.66%±20.01% (n=13) in anti-thyroid drugs plus Chinese drugs group, 2.11%±1.78% (n=13) in single anti-thyroid drug group (P<0.01). For up to 2-10 weeks, more TUNEL-positive cells were found after treatment with Chinese drugs than those treated with anti-thyroid drug alone. Conclusion: Some Chinese drugs when used in combination with anti-thyroid drugs in treating Graves' disease could induce apoptosis of thyrocytes. 展开更多
关键词 graves' disease THYROCYTES APOPTOSIS Chinese drugs
原文传递
上一页 1 2 下一页 到第
使用帮助 返回顶部